BioInnovation Institute backs five startups with €1.3M in follow-on funding

Copenhagen, Denmark — In a bold move that underscores Europe’s rising dominance in life sciences and deep tech, the BioInnovation Institute (BII) has announced an additional €1.3 million in follow-on funding for five cutting-edge startups, bringing the total support per company to an impressive €1.8 million. This latest investment is part of BII’s broader mission to transform groundbreaking research into commercially viable solutions that address some of the world’s most pressing challenges in health, agriculture, climate, and technology.

The funding announcement comes on the heels of a monumental commitment by the Novo Nordisk Foundation, which has pledged up to €736 million (DKK 5.5 billion) to BII. This unprecedented investment will enable the Copenhagen-based institute to expand its reach into new strategic areas and geographies, while supporting a larger number of entrepreneurs and startups across Europe. Since its establishment in 2018, BII has been a beacon for early-stage research and startups, providing not just funding but also state-of-the-art facilities and business support to help translate scientific discoveries into thriving companies.

The latest round of funding is being deployed through BII’s Venture House programme, a cornerstone of its mission to bridge the gap between innovation and market deployment. The five startups selected for this funding round represent a diverse array of sectors, each tackling unique challenges with innovative solutions:

Synuca Therapeutics is making waves as the first company funded through the DKK320 million innovation partnership with Lundbeckfonden/Lundbeck Foundation. The startup is developing a first-in-class disease-modifying therapy for Parkinson’s disease and related brain disorders, offering hope to millions of patients worldwide.

Gefjon Pharma is revolutionizing the vaccine and therapeutics landscape with its outer membrane vesicle (OMV) platform. By producing cost-effective vaccines and therapeutics, the company aims to reduce antimicrobial use, starting with E. coli infections in poultry.

MicroMiner is addressing the sustainability challenges of electric vehicle (EV) batteries with its advanced recycling technology. As the world transitions to greener energy solutions, MicroMiner’s innovations are poised to play a critical role in making EV batteries more sustainable.

DARERL is pushing the boundaries of medical device design with its SaaS platform that provides high-fidelity digital human anatomy models. This technology is set to transform the way wearable and medical devices are designed and validated, ensuring greater precision and efficacy.

Diasense is at the forefront of quantum diagnostics with its industrial-grade quantum diamond microscope. This cutting-edge tool delivers real-time diagnostics and process insights for next-generation semiconductor manufacturing, a critical component of the global tech ecosystem.

Trine Bartholdy, Chief Business Officer at BII, expressed her enthusiasm for the selected startups, stating, “All five companies clearly reflect BII’s mission to enable novel solutions that benefit human health, planetary health, and societal resilience. We are proud to continue supporting them through our Venture House program and help bring them closer to external investment and commercialisation.”

Each of these startups had previously received €500,000 from BII, and the additional funding will enable them to advance key milestones. From lead optimization in neurodegenerative disease research to scaling vaccine production and industrializing quantum diagnostic tools, these companies are poised to make significant strides in their respective fields.

This latest funding round is a testament to BII’s commitment to fostering innovation and driving societal impact. By supporting startups that are tackling some of the most complex challenges of our time, BII is not only shaping the future of life sciences and deep tech but also positioning Europe as a global leader in these critical sectors.

As the world grapples with issues ranging from climate change to healthcare disparities, the work being done by these startups offers a glimpse of hope and progress. With the backing of BII and the Novo Nordisk Foundation, these companies are well-equipped to turn their visionary ideas into reality, paving the way for a healthier, more sustainable, and technologically advanced future.

Tags & Viral Phrases:

• BioInnovation Institute
• Novo Nordisk Foundation
• €736 million investment
• Life sciences incubator
• Deep tech startups
• Venture House programme
• Disease-modifying therapy
• Parkinson’s disease research
• Outer membrane vesicle platform
• EV battery recycling
• Digital human anatomy models
• Quantum diamond microscope
• Semiconductor manufacturing
• Societal resilience
• Commercialisation support
• European innovation powerhouse
• Cutting-edge research
• Sustainable solutions
• Healthcare innovation
• Tech ecosystem transformation

,